{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:48:56Z","timestamp":1792097336997,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011566","name":"Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center","doi-asserted-by":"publisher","award":["P30CA006973"],"award-info":[{"award-number":["P30CA006973"]}],"id":[{"id":"10.13039\/100011566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009075","name":"Bankhead-Coley Foundation","doi-asserted-by":"publisher","award":["24B16"],"award-info":[{"award-number":["24B16"]}],"id":[{"id":"10.13039\/100009075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ebiom.2025.105895","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T23:51:05Z","timestamp":1756857065000},"page":"105895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A sensitive and specific non-invasive urine biomarker panel for prostate cancer detection"],"prefix":"10.1016","volume":"119","author":[{"given":"Menglang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio Covas","family":"Moschovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2153-0110","authenticated-orcid":false,"given":"Kandarp","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Sanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshane A.","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongyong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudramani","family":"Pokhrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Jiri","family":"Polivka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest K.","family":"Amankwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Gonzalez-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naren","family":"Nimmagadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra","family":"Baraban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4614-2747","authenticated-orcid":false,"given":"Anant","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuncong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inoel","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guru P.","family":"Sonpavde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Bettegowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Pavlovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjan J.","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2025.105895_bib1","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"24","key":"10.1016\/j.ebiom.2025.105895_bib2","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2017.7248","article-title":"The diagnosis and treatment of prostate cancer: a review","volume":"317","author":"Litwin","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105895_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.2246","article-title":"Trends in incidence of metastatic prostate cancer in the US","volume":"5","author":"Desai","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"22","key":"10.1016\/j.ebiom.2025.105895_bib4","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1002\/cncr.28932","article-title":"Expected population impacts of discontinued prostate-specific antigen screening","volume":"120","author":"Gulati","year":"2014","journal-title":"Cancer"},{"issue":"13","key":"10.1016\/j.ebiom.2025.105895_bib5","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105895_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.eururo.2019.02.009","article-title":"A 16-yr Follow-up of the European randomized study of screening for prostate cancer","volume":"76","author":"Hugosson","year":"2019","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105895_bib7","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1001\/jamaoncol.2022.4319","article-title":"Association of prostate-specific antigen screening rates with subsequent metastatic prostate cancer incidence at US veterans health administration facilities","volume":"8","author":"Bryant","year":"2022","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105895_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamaoncol.2021.5143","article-title":"Changes in prostate-specific antigen testing relative to the revised US preventive services task force recommendation on prostate cancer screening","volume":"8","author":"Leapman","year":"2022","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105895_bib9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.eururo.2017.10.036","article-title":"Genomic markers in prostate cancer decision making","volume":"73","author":"Cucchiara","year":"2018","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105895_bib10","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3390\/cancers11091244","article-title":"Review and comparison of cancer biomarker trends in urine as a basis for new diagnostic pathways","volume":"11","author":"Bax","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"23","key":"10.1016\/j.ebiom.2025.105895_bib11","first-page":"5975","article-title":"DD3: a new prostate-specific gene, highly overexpressed in prostate cancer","volume":"59","author":"Bussemakers","year":"1999","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105895_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0302-2838(03)00201-X","article-title":"DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer","volume":"44","author":"Hessels","year":"2003","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105895_bib13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.eururo.2010.06.039","article-title":"Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test","volume":"58","author":"Roobol","year":"2010","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105895_bib14","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2016.04.012","article-title":"Detection of high-grade prostate cancer using a urinary molecular biomarker-based risk score","volume":"70","author":"Van Neste","year":"2016","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105895_bib15","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamaoncol.2016.0097","article-title":"A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy","volume":"2","author":"McKiernan","year":"2016","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105895_bib16","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/jamaoncol.2017.0177","article-title":"Association between combined TMPRSS2:ERG and PCA3 RNA urinary testing and detection of aggressive prostate cancer","volume":"3","author":"Sanda","year":"2017","journal-title":"JAMA Oncol"},{"issue":"5S","key":"10.1016\/j.ebiom.2025.105895_bib17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.6004\/jnccn.2018.0036","article-title":"NCCN guidelines updates: prostate cancer and prostate cancer early detection","volume":"16","author":"Carroll","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"22","key":"10.1016\/j.ebiom.2025.105895_bib18","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter","volume":"350","author":"Thompson","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105895_bib19","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.juro.2014.10.121","article-title":"The prostate health index selectively identifies clinically significant prostate cancer","volume":"193","author":"Loeb","year":"2015","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105895_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/pros.24801","article-title":"Serum levels of prostate specific antigen, free PSA, [-2]proPSA, fPSA\/tPSA ratio, prostate health index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy","volume":"85","author":"Jir\u00e1sko","year":"2025","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105895_bib21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.eururo.2014.10.021","article-title":"A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer","volume":"68","author":"Parekh","year":"2015","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105895_bib22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/pros.23495","article-title":"The effect of digital rectal exam on the 4Kscore for aggressive prostate cancer","volume":"78","author":"Maccini","year":"2018","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105895_bib23","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1038\/s41598-020-60616-z","article-title":"Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105895_bib24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jmoldx.2014.06.009","article-title":"Long noncoding RNAs as putative biomarkers for prostate cancer detection","volume":"16","author":"Lee","year":"2014","journal-title":"J Mol Diagn"},{"issue":"22","key":"10.1016\/j.ebiom.2025.105895_bib25","doi-asserted-by":"crossref","first-page":"7774","DOI":"10.1021\/acs.analchem.1c00943","article-title":"Rapid diagnosis of prostate cancer disease progression using paper spray ionization mass spectrometry","volume":"93","author":"Mahmud","year":"2021","journal-title":"Anal Chem"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105895_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093721","article-title":"The DCR protein TTC3 affects differentiation and golgi compactness in neurons through specific actin-regulating pathways","volume":"9","author":"Berto","year":"2014","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105895_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1158\/1541-7786.MCR-14-0474","article-title":"A mechanism for asymmetric cell division resulting in proliferative asynchronicity","volume":"13","author":"Dey-Guha","year":"2015","journal-title":"Mol Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105895_bib28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.humpath.2003.08.026","article-title":"Frequent EpCam protein expression in human carcinomas","volume":"35","author":"Went","year":"2004","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105895_bib29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ncb1824","article-title":"Nuclear signalling by tumour-associated antigen EpCAM","volume":"11","author":"Maetzel","year":"2009","journal-title":"Nat Cell Biol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105895_bib30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/bjc.2013.744","article-title":"Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential","volume":"110","author":"Bryan","year":"2014","journal-title":"Br J Cancer"},{"issue":"48","key":"10.1016\/j.ebiom.2025.105895_bib31","doi-asserted-by":"crossref","first-page":"24075","DOI":"10.1073\/pnas.1908052116","article-title":"mRNA structure regulates protein expression through changes in functional half-life","volume":"116","author":"Mauger","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105895_bib32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41576-024-00810-1","article-title":"Cytoplasmic mRNA decay and quality control machineries in eukaryotes","volume":"26","author":"Dowdle","year":"2025","journal-title":"Nat Rev Genet"},{"issue":"14","key":"10.1016\/j.ebiom.2025.105895_bib33","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1093\/nar\/gkr226","article-title":"Messenger RNA degradation is initiated at the 5' end and follows sequence- and condition-dependent modes in chloroplasts","volume":"39","author":"Salvador","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105895_bib34","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2017.04.036","article-title":"Widespread influence of 3'-End structures on mammalian mRNA processing and stability","volume":"169","author":"Wu","year":"2017","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105895_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112840","article-title":"Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3' untranslated region mutations","volume":"42","author":"Schuster","year":"2023","journal-title":"Cell Rep"},{"issue":"43","key":"10.1016\/j.ebiom.2025.105895_bib36","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2025.105895_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-med-060413-112226","article-title":"Molecular profiles of prostate cancer: to treat or not to treat","volume":"67","author":"Sternberg","year":"2016","journal-title":"Annu Rev Med"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105895_bib38","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41571-020-0332-z","article-title":"All change in the prostate cancer diagnostic pathway","volume":"17","author":"Lomas","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105895_bib39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","article-title":"NCCN guidelines\u00ae insights: prostate cancer, version 3.2024","volume":"22","author":"Schaeffer","year":"2024","journal-title":"J Natl Compr Canc Netw"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425003391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425003391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:40:09Z","timestamp":1772905209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425003391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":39,"alternative-id":["S2352396425003391"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105895","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A sensitive and specific non-invasive urine biomarker panel for prostate cancer detection","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105895","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105895"}}